top of page
Mon, May 03|
New Cancer Immunotherapy Targets Genetic Alteration in All Cancers
Researchers have developed a prototype for a new kind of cancer immunotherapy. The therapy uses engineered T-cells to target a genetic alteration common among all cancers.
Registration is ClosedSee other events
bottom of page